Dr. Reddy's Laboratories Limited
Hedge Funds Holdings
Last updated:
Dr. Reddy's Laboratories Limited‘s stocks are currently a part of 142 hedge funds’ portfolios, which represents 8.65% of the total amount of its stocks outstanding. This makes up a total of 14.39M shares of Dr. Reddy's Laboratories Limited. Compared to the previous quarter, the number fell by -7.97% or -1.24M shares fewer. As for the holding position changes, 40.85% (58) of current hedge fund investors increased the number of shares held, 28.17% (40) of current holders sold a part of the shares held, and 7.04% (10) closed the holdings completely. 17 hedge funds are new holders of Dr. Reddy's Laboratories Limited stock in Q3 2022, it is 11.97% of total holders.
Hedge funds holding Dr. Reddy's Laboratories Limited (Q4 2017 – Q3 2022)
Q4 2017 | 116 |
---|---|
Q1 2018 | 120 |
Q2 2018 | 136 |
Q3 2018 | 124 |
Q4 2018 | 144 |
Q1 2019 | 142 |
Q2 2019 | 147 |
Q3 2019 | 150 |
Q4 2019 | 145 |
Q1 2020 | 147 |
Q2 2020 | 167 |
Q3 2020 | 183 |
Q4 2020 | 172 |
Q1 2021 | 158 |
Q2 2021 | 158 |
Q3 2021 | 146 |
Q4 2021 | 143 |
Q1 2022 | 142 |
Q2 2022 | 147 |
Q3 2022 | 142 |
Hedge funds changes in Dr. Reddy's Laboratories Limited positions (Q4 2017 – Q3 2022)
Q4 2017 | 11 | 32 | 46 | 13 | 14 |
---|---|---|---|---|---|
Q1 2018 | 21 | 34 | 41 | 17 | 7 |
Q2 2018 | 29 | 49 | 33 | 12 | 13 |
Q3 2018 | 20 | 42 | 39 | 32 | -9 |
Q4 2018 | 32 | 56 | 33 | 12 | 11 |
Q1 2019 | 18 | 57 | 39 | 20 | 8 |
Q2 2019 | 24 | 54 | 45 | 19 | 5 |
Q3 2019 | 18 | 50 | 52 | 14 | 16 |
Q4 2019 | 18 | 44 | 50 | 22 | 11 |
Q1 2020 | 22 | 46 | 47 | 19 | 13 |
Q2 2020 | 32 | 42 | 64 | 12 | 17 |
Q3 2020 | 35 | 52 | 66 | 16 | 14 |
Q4 2020 | 15 | 48 | 74 | 25 | 10 |
Q1 2021 | 24 | 54 | 48 | 37 | -5 |
Q2 2021 | 23 | 52 | 48 | 21 | 14 |
Q3 2021 | 10 | 48 | 57 | 20 | 11 |
Q4 2021 | 22 | 41 | 50 | 23 | 7 |
Q1 2022 | 21 | 51 | 42 | 23 | 5 |
Q2 2022 | 24 | 51 | 44 | 16 | 12 |
Q3 2022 | 17 | 58 | 40 | 10 | 17 |
Hedge funds changes in Dr. Reddy's Laboratories Limited stock options (Q4 2017 – Q3 2022)
Q4 2017 | 357,000 | 1,302,000 |
---|---|---|
Q1 2018 | 559,000 | 1,268,000 |
Q2 2018 | 361,000 | 929,000 |
Q3 2018 | 630,000 | 256,000 |
Q4 2018 | 1,187,000 | 497,000 |
Q1 2019 | 664,000 | 534,000 |
Q2 2019 | 274,000 | 247,000 |
Q3 2019 | 394,000 | 22,000 |
Q4 2019 | 227,000 | 321,000 |
Q1 2020 | 480,000 | 363,000 |
Q2 2020 | 1,405,000 | 1,102,000 |
Q3 2020 | 1,753,000 | 2,253,000 |
Q4 2020 | 770,000 | 1,918,000 |
Q1 2021 | 571,000 | 1,577,000 |
Q2 2021 | 1,926,000 | 1,345,000 |
Q3 2021 | 1,759,000 | 4,448,000 |
Q4 2021 | 366,000 | 366,000 |
Q1 2022 | 424,000 | 535,000 |
Q2 2022 | 0 | 222,000 |
Q3 2022 | 0 | 0 |